These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38145237)

  • 1. Utilization, reimbursement, and price trends for Hepatitis C virus medications in the US Medicaid programs: 2001-2021.
    Gari MH; Alsuhibani A; Alashgar A; Guo JJ
    Explor Res Clin Soc Pharm; 2023 Dec; 12():100383. PubMed ID: 38145237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015.
    Lu CY; Zhang F; Golonski N; Lupton C; Jeffrey P; Wagner AK
    Value Health; 2018 Jun; 21(6):692-697. PubMed ID: 29909874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Expenditure, Price, and Utilization in the U.S. Medicaid: A Trend Analysis for SSRI and SNRI Antidepressants from 1991 to 2018.
    Alrasheed M; Hincapie AL; Guo JJ
    J Ment Health Policy Econ; 2021 Mar; 24(1):3-11. PubMed ID: 33739932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization, Spending, and Price of Opioid Medications in the US Medicaid Programs Between 1991 and 2019.
    Alsultan MM; Guo JJ
    Am Health Drug Benefits; 2022 Mar; 15(1):31-37. PubMed ID: 35586617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries.
    Barber MJ; Gotham D; Khwairakpam G; Hill A
    J Virus Erad; 2020 Sep; 6(3):100001. PubMed ID: 33251019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Utilization, Spending, and Prices of Smoking-Cessation Medications in Medicaid Programs: 25 Years Empirical Data Analysis, 1991-2015.
    Yue X; Guo JJ; Wigle PR
    Am Health Drug Benefits; 2018 Sep; 11(6):275-285. PubMed ID: 30464795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization, spending, and price trends for short- and long-acting Beta-agonists and inhaled corticosteroids in the medicaid program, 1991-2010.
    Chiu SF; Kelton CM; Guo JJ; Wigle PR; Lin AC; Szeinbach SL
    Am Health Drug Benefits; 2011 May; 4(3):140-9. PubMed ID: 25126346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Utilization, Expenditure, and Price of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the US Medicaid Programs: Trends Over a 31 Year Period.
    Almadfaa RO; Wigle PR; Hincapie AL; Guo JJ
    Int J Cardiol; 2023 Jan; 370():412-418. PubMed ID: 36306953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the burden of illness of chronic hepatitis C and impact of direct-acting antiviral use on healthcare costs in Medicaid.
    Roebuck MC; Liberman JN
    Am J Manag Care; 2019 Jun; 25(8 Suppl):S131-S139. PubMed ID: 31211526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Expenditure, Price, and Utilization in US Medicaid: A Trend Analysis for New Multiple Myeloma Medications from 2016 to 2022.
    Alrasheed M; Alsuhibani A; Balkhi B; Guo JJ
    Healthcare (Basel); 2023 Aug; 11(16):. PubMed ID: 37628464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the utilization of, spending on, and prices for outpatient antifungal agents in US Medicaid programs: 1991-2009.
    Desai VC; Cavanaugh TM; Kelton CM; Guo JJ; Heaton PC
    Clin Ther; 2012 Oct; 34(10):2118-2131.e1. PubMed ID: 23031625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of relaxing hepatitis C treatment restrictions on direct-acting antiviral use in a Medicaid program: an interrupted time series analysis.
    Herink MC; Geddes J; Vo K; Zaman A; Hartung DM
    J Manag Care Spec Pharm; 2021 Jul; 27(7):856-864. PubMed ID: 34185560
    [No Abstract]   [Full Text] [Related]  

  • 14. Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010-2015.
    Zimmermann R; Kollan C; Ingiliz P; Mauss S; Schmidt D; Bremer V
    J Hepatol; 2017 Jul; 67(1):15-22. PubMed ID: 28189752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis.
    Iyengar S; Tay-Teo K; Vogler S; Beyer P; Wiktor S; de Joncheere K; Hill S
    PLoS Med; 2016 May; 13(5):e1002032. PubMed ID: 27243629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Drug Costs of Treating Hepatitis C Genotypes 1-4 with Direct-Acting Antivirals: Initiating Treatment at Fibrosis 0-2 and 3-4.
    Bach TA; Zaiken K
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1437-1445. PubMed ID: 27882839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High rates of hepatitis C virus (HCV) cure using direct-acting antivirals in HIV/HCV-coinfected patients: a real-world perspective.
    Hawkins C; Grant J; Ammerman LR; Palella F; Mclaughlin M; Green R; Mcgregor D; Stosor V
    J Antimicrob Chemother; 2016 Sep; 71(9):2642-5. PubMed ID: 27330060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expenditure, Utilization, and Cost of Specialty Drugs for Multiple Sclerosis in the US Medicaid Population, 2008-2018.
    Elsisi Z; Hincapie AL; Guo JJ
    Am Health Drug Benefits; 2020 May; 13(2):74-84. PubMed ID: 32724502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spending, Utilization, and Price Trends for Immune Checkpoint Inhibitors in US Medicaid Programs: An Empirical Analysis from 2011 to 2021.
    Shin YE; Kumar A; Guo JJ
    Clin Drug Investig; 2023 Apr; 43(4):289-298. PubMed ID: 37005969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Medicaid excess payments from alleged price manipulation of generic lorazepam.
    Bian B; Gorevski E; Kelton CM; Guo JJ; Martin Boone JE
    J Manag Care Pharm; 2012 Sep; 18(7):506-15. PubMed ID: 22971204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.